1. Phase angle and standardized phase angle from bioelectrical impedance measurements as a prognostic factor for mortality at 90 days in patients with COVID-19: A longitudinal cohort study
- Author
-
Francisco J. Tinahones, Diego Bellido-Guerrero, Jose Manuel García-Almeida, Henry C. Lukaski, Isabel M. Vegas-Aguilar, Antonio Talluri, and Isabel Cornejo-Pareja
- Subjects
Adult ,0301 basic medicine ,medicine.medical_specialty ,Prognostic factor ,Coronavirus disease 2019 (COVID-19) ,Nutritional Status ,030209 endocrinology & metabolism ,Critical Care and Intensive Care Medicine ,Age and sex ,Gastroenterology ,Cohort Studies ,03 medical and health sciences ,0302 clinical medicine ,Bioelectrical impedance ,Internal medicine ,Electric Impedance ,medicine ,Humans ,In patient ,Longitudinal Studies ,Mortality ,Longitudinal cohort ,Survival analysis ,Inflammation ,030109 nutrition & dietetics ,Nutrition and Dietetics ,business.industry ,Phase angle ,COVID-19 ,Prognosis ,Body Composition ,Original Article ,business ,Bioelectrical impedance analysis ,Biomarkers - Abstract
Background & aims Severe acute COVID-19 has taken on pandemic proportions with growing interest in identification of prognostic factors for mortality. Standardized bioelectrical impedance (BI) phase angle (SPhA), which is PhA adjusted by age and sex, has been related to mortality in patients with several diseases but never investigated in COVID-19. Inflammation, a consequence of COVID-19 infection, affects fluid status (hydration) and can be identified with PhA. The aim of this study was to determine the predictive role of PhA on 90 days survival of adults with COVID-19. Methods We studied 127 consecutive patients diagnosed with COVID-19. BI measurements determined with a 50 kHz phase-sensitive BI device, body composition parameters and laboratory markers were evaluated as predictors of mortality. Results Non-surviving COVID-19 patients had significantly lower PhA and SPhA values (p
- Published
- 2022